Diabetes care, 44(10), 2388-2396. American Diabetes Association Inc. van Duinkerken, E, Ijzerman, R G, Barkhof, F, Moll, A C, Diamant, M, Snoek, F J & Klein, M 2021, ' Cognitive Functioning and Hippocampal Connectivity in Patients With Longstanding Type 1 Diabetes and Apolipoprotein E ɛ4 ', Diabetes Care, vol. 44, no. 10, pp. 2388-2396 . https://doi.org/10.2337/DC21-0483 Diabetes Care, 44(10), 2388-2396. American Diabetes Association Inc.
Diabetes, Obesity and Metabolism, 23(8), 1851-1858. Wiley Diabetes, obesity & metabolism, 23(8), 1851-1858. Wiley-Blackwell Diabetes, Obesity and Metabolism, 23(8), 1851-1858. Wiley-Blackwell van Ruiten, C C, van der Aart-van der Beek, A B, IJzerman, R G, Nieuwdorp, M, Hoogenberg, K, van Raalte, D H & Heerspink, H J L 2021, ' Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial ', Diabetes, Obesity and Metabolism, vol. 23, no. 8, pp. 1851-1858 . https://doi.org/10.1111/dom.14410 Diabetes, Obesity & Metabolism
Diabetes, obesity & metabolism, 24(8), 1588-1597. Wiley-Blackwell van Ruiten, C C, Veltman, D J, Wijdeveld, M, ten Kulve, J S, Kramer, M H H, Nieuwdorp, M & IJzerman, R G 2022, ' Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes : A randomized controlled trial ', Diabetes, Obesity and Metabolism, vol. 24, no. 8, pp. 1588-1597 . https://doi.org/10.1111/dom.14732 Diabetes, Obesity and Metabolism, 24(8), 1588-1597. Wiley-Blackwell